Working With DMD Patient Organizations

DMD patient organizations are the non-profit groups that sit between families and the rest of the Duchenne muscular dystrophy ecosystem: clinicians, researchers, regulators, insurers, and schools. They fund research, publish care guidance, run conferences, support families directly, and lobby governments. Most families use at least one of them; few use them as fully as they could.

This post is a practical guide to what these organizations do and how to get the most out of them.

Why patient organizations matter

DMD is rare, and the everyday systems that families need (insurance, equipment vendors, schools, hospitals, employers) are not built around the disease. Patient organizations exist to close that gap. They are also where the practical knowledge of the community accumulates over time, in a form that survives any single family’s energy.

The 2018 international care considerations describe patient organizations as part of the broader care ecosystem, not a replacement for clinical care. (Birnkrant et al., Lancet Neurology 2018, Part 1)

The main organizations

A non-exhaustive list of well-established organizations, grouped by scope:

DMD-specific, United States

• Parent Project Muscular Dystrophy (PPMD) — research funding, family resources, advocacy, the Annual Conference, Connect groups by state and topic, and the Insurance Access and Coverage Center. (PPMD, For Families)
• CureDuchenne — research investment focused on therapy development, family programs including CureDuchenne Cares clinical workshops, and an active emergency and equipment grant program.
• Jett Foundation — equipment grants (Jett Giving Fund), trial-readiness support, and family programs including summer camp.
• Little Hercules Foundation, Charley’s Fund, Hope for Javier, Cure Rare Disease, and several smaller organizations each focused on specific research or family-support angles.

Broader neuromuscular, United States

• Muscular Dystrophy Association (MDA) — multi-disease scope including DMD; MDA Care Centers, summer camps, equipment loan and assistance programs, advocacy work, and the annual MDA Clinical and Scientific Conference.

International

• Duchenne UK — research funding and family support across the United Kingdom.
• World Duchenne Organization — international coordination, including World Duchenne Awareness Day each September 7.
• Action Duchenne (United Kingdom), Duchenne Parent Project networks across continental Europe and Brazil, JOIN-DMD (Japan), DMD India, and dozens of national groups.

This is not a complete list. The geographic and disease coverage of patient organizations continues to expand.

What they do for families

The day-to-day services families use most often are typically:

• Care guidance: standards summaries, clinic locator tools, and disease-stage guides for newly diagnosed families.
• Equipment and grant programs: matching funds for wheelchairs, accessible vehicles, home modifications, and other equipment insurance will not fully cover.
• Insurance and access support: appeal letter templates, navigation help, copay program directories.
• School resources: teacher guides, accommodation templates, advocacy support.
• Mental health and respite: peer support, sibling programs, parent mentoring, respite grants.
• Conferences and camps: family conferences (PPMD Annual Conference, MDA Conference) and disease-specific summer camps.
• Connect groups: local groups of families that meet in person or online. PPMD’s Connect program has expanded to more than 25 US states. (PPMD, Find a Local Connect Group)

For background on practical financial coverage, see financial planning and insurance for Duchenne families.

What they do for research

Patient organizations have become serious research funders in DMD. Their roles include direct grants to academic and biotech research, support for natural-history studies and patient registries, organization of clinical-trial readiness programs, and convening of regulators, clinicians, and patients.

Several of the disease-modifying therapies on the market today were supported, at some stage of development, by patient organization funding. The patient-led nomination of Duchenne to the United States Recommended Uniform Screening Panel in December 2025 is another example of what sustained organizational work can deliver.

For background, see DMD patient advocacy history and newborn screening for DMD.

How families can engage

A practical staged approach for newly diagnosed families:

1. Subscribe to updates from at least one DMD-specific organization. Most publish a newsletter that surfaces important guidelines, trial news, and family resources.
2. Use the care guides. The PPMD Care Guide and equivalent resources from MDA and CureDuchenne are short, accessible, and worth a quiet evening to read.
3. Join a local Connect group or its equivalent. Other families know things that no clinician or website does.
4. Apply for grants when you need them, not when the equipment is on order. Decisions take time.
5. Attend a conference at least once. The first family conference is consistently described by parents as one of the most useful single experiences of the early disease years.
6. Consider participation in a registry. Patient registries support natural-history understanding and trial recruitment.

For background, see the first year after a DMD diagnosis.

How families can give back

Many families eventually want to contribute beyond their own child’s care. Options range from low-effort to high-effort:

• Fundraising for a chosen organization.
• Sharing their family’s story for awareness campaigns.
• Participating in patient-focused drug development meetings convened by regulators.
• Volunteering for committees, advisory boards, or peer-support roles.
• Becoming a Connect group leader.
• Speaking at conferences.

For background, see from parent to advocate, a practical guide.

Choosing among organizations

Most families end up engaging with more than one. Practical considerations when choosing where to put time and attention:

• Local presence: a national organization with a strong local chapter near the family is often more useful day-to-day than one without.
• Specific service fit: equipment grants, school support, conferences, and research engagement all live in different programs.
• Approach and culture: organizations differ in tone, communication style, and how they engage with industry. Families pick what fits.
• Specific focus: some organizations concentrate on one research strategy or one disease stage; that may match or not match a family’s situation.

Joining one organization does not preclude others. The disease is bigger than any single group.

What is still uncertain

The role of patient organizations continues to evolve, particularly around the boundary between patient advocacy and industry partnership. Different organizations handle these questions differently, and families often appreciate transparency about how their chosen organizations operate.

The reasonable framing is that DMD patient organizations are one of the most underused resources in the disease, and that investing the time to engage with them produces both practical and emotional return.

For related reading, see from parent to advocate, a practical guide, DMD patient advocacy history, financial planning and insurance for Duchenne families, the first year after a DMD diagnosis, and the reported pieces Children Waiting While Time Runs Out and The Same Disease, Different Countries.

Disclaimer: This post is informational and does not constitute medical advice. Decisions about diagnosis or treatment must be made with a qualified care team.